UGA researchers to explore ‘parasitic’ DNA with $1.13 million NIH grant

Garfinkel.h-lab

November 3, 2011

Print
Share    
Writer:
Sam Fahmy

Sam Fahmy

Director of Public Relations

Recent and archived articles by Sam Fahmy

Office of the Senior Vice President for Academic Affairs and Provost
Administration Building
220 South Jackson Street
Athens, GA
Work: 706-583-0727
Email:


Photography

  • magnify Garfinkel.h-lab

    Members of Garfinkel's lab include (l-r) Linda Eizenstat, lab technician; Agniva Saha, graduate student in biochemistry; Garfinkel; Jessica Mitchell, graduate student in biochemistry.

Scroll Left 1 Scroll Right

Related Sites

Athens, Ga. - With his discovery of a new class of molecules that put the brakes on the movement of so-called parasitic DNA, University of Georgia researcher David Garfinkel raised several questions that have yet to be answered, namely: Do these molecules work and, more broadly, what can they tell us about how cells handle assaults from viruses such as HIV and conditions such as macular degeneration?

Now, with a $1.13 million grant from the National Institutes of Health, Garfinkel, a professor of biochemistry and molecular biology in the Franklin College of Arts and Sciences, is exploring how molecules known as antisense RNAs inhibit the movement of transposons.

"Upwards of 40 percent of the content of our chromosomes are transposons, and we don't understand much about how they attain that copy number and what roles they play in normal genome function as well as when things go awry," Garfinkel said. "Those are the kinds of fundamental questions that I'm interested in."

The transposons that Garfinkel studies make additional copies of themselves and insert those copies throughout the genome. These "jumping genes" are often thought of as genetic parasites, but Garfinkel pointed out that they actually benefit the host in some cases. By giving cells new combinations of genes and forms of gene regulation to work with, for example, transposons allow them to quickly adapt to changing conditions. And unlike retroviruses such as their pathogenic cousin HIV, which also makes copies of itself and then inserts them into its host, transposons generally leave their hosts unharmed and intact.

Garfinkel studies what are called Ty1 retrotransposons in baker's yeast, an organism that has the same basic cellular machinery as more complex forms of life, humans included, yet is much easier to work with and better understood. Within cells, DNA is transcribed into messenger RNA, which is then translated into proteins that do much of the work of cells. In a study published in 2009 in the journal Proceedings of the National Academy of Sciences, Garfinkel and co-author Emiko Matsuda of the National Cancer Institute showed that Ty1 produces non-coding antisense RNAs that poison at least one transposon protein, thereby preventing the element from making its genetic leap.

Like a thermostat, the antisense RNAs respond to conditions within the cell to keep the level of transposition within a given range. As the number of transposons in the cell increase, so do the levels of antisense RNAs. If the number of transposons drops, the levels of antisense RNAs drop and allow the number of transposons to rise again.

Interestingly, yeast lost the surveillance system, called RNA interference, that tames transposons and helps maintain normal cell functions in other organisms, including humans. Although yeast lacks the RNAi genes, the reliance on non-coding RNAs to inhibit element propagation remains intact. However, in conditions such as macular degeneration, a leading cause of age-related blindness, the RNAi protein known as dicer that is supposed to keep cells healthy goes AWOL.

"The fact that there are now pathologies associated with the lack of RNAi proteins is a good lead for us to explore the relationships with human health," Garfinkel said, "because it's starting to recapitulate the situation that's found naturally in budding yeast."

Garfinkel, who came to UGA after a 25-year career with the NCI, said the grant also creates opportunities for collaborations with other labs on campus. His team is primarily concerned with the molecular genetics of the antisense RNA, but he's also interested in understanding how the molecule binds to proteins or other targets in the cell.

"We're on the leading edge of discovery here, so there isn't a huge set of precedents we can simply plug our work into," Garfinkel said, explaining that the role the antisense RNAs might play in other organisms is still unclear. "We'll just have to work hard, and wait and see whether this new form of RNAi appears elsewhere. Given that budding yeast is a powerful model for understanding fundamental cellular processes, I suspect what we discovered will be found in other organisms."

##

Note to editors: An image of Garfinkel's lab staff is available for download at http://multimedia.uga.edu/media/images/Garfinkel_lab.jpg

Caption: Members of Garfinkel's lab include (l-r) Linda Eizenstat, lab technician; Agniva Saha, graduate student in biochemistry; Garfinkel; Jessica Mitchell, graduate student in biochemistry.

Credit: Photo by Paul Efland/University of Georgia.

 

 

Filed under: University News

News Service

Director
Cynthia Hoke

706 / 542-8083
Public Relations Coordinator
Stephanie Schupska

706 / 542-6927
Public Relations Coordinator
Sara Freeland

706 / 542-8077
Science Writer
April Sorrow

706 / 542-7991

Broadcast, Video and Photography

Director
Steve Bell

706 / 542-8089
Broadcast Coordinator
Pete Konenkamp

706 / 542-8080
Photography
Rick O‘Quinn

706 / 542-8085